ENVB icon

Enveric Biosciences
ENVB

Overview Fund Activity

10 hedge funds and large institutions have $1.77M invested in Enveric Biosciences in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.

Holders
10
Holders Change
+4
Holders Change %
+66.67%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
1
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Hudson Bay Capital Management
1
Hudson Bay Capital Management
Connecticut
$1.24M
2
TA
2
Tiedemann Advisors
New York
$245K
3
Millennium Management
3
Millennium Management
New York
$155K
4
Goldman Sachs
4
Goldman Sachs
New York
$46K
5
CS
5
Cannell & Spears
New York
$22K

Top Sellers

1
Jane Street
1
Jane Street
New York
$0
2
CF
2
Centaurus Financial
California
$0
3
JA
3
JOYN Advisors
Georgia
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Hudson Bay Capital Management
1
Hudson Bay Capital Management
Connecticut
$1.24M 1,000,000 +1,000,000 New
TA
2
Tiedemann Advisors
New York
$245K 188,723 +188,723 New
Millennium Management
3
Millennium Management
New York
$155K 119,397 +119,397 New
Goldman Sachs
4
Goldman Sachs
New York
$46K 35,023 +35,023 New
UBS Group
5
UBS Group
Switzerland
$25K 19,411 +10,554 +119%
CS
6
Cannell & Spears
New York
$22K 17,165 +17,165 New
FCH
7
Freestone Capital Holdings
Washington
$17K 13,208 +13,208 New
TSS
8
Two Sigma Securities
New York
$16K 12,125 +12,125 New
Bank of America
9
Bank of America
North Carolina
$4K 3,005 +3,005 New
Jane Street
10
Jane Street
New York
– – -10,774 Closed
CF
11
Centaurus Financial
California
– – -10,000 Closed
JA
12
JOYN Advisors
Georgia
– – -845 Closed
CIBC Private Wealth Group
13
CIBC Private Wealth Group
Georgia
– – -100 Closed
Morgan Stanley
14
Morgan Stanley
New York
$0 18 – –